Juvenile rheumatoid arthritis, juvenile chronic arthritis, and juvenile spondyloarthropathies

B M Ansell1

  • 1Consulting Rooms, Windsor, UK.

Insights

Immunogenetics reveal diverse chronic childhood arthritis types. Early-onset pauciarticular disease links to specific HLA types, while methotrexate effectively manages polyarthritis in juvenile rheumatoid arthritis.

Area of Science:

  • Pediatric Rheumatology
  • Immunogenetics
  • Clinical Trial Analysis

Background:

  • Chronic arthritis in children exhibits significant heterogeneity.
  • Specific human leukocyte antigen (HLA) types, including DRw13-DRw18 and DQw6-DQw18, are associated with persistent pauciarticular disease in early-onset pediatric arthritis.
  • DPw2 is identified as an additional susceptibility factor in this subgroup.

Purpose of the Study:

  • To explore the immunogenetic basis of chronic childhood arthritis heterogeneity.
  • To evaluate the efficacy of methotrexate in managing juvenile rheumatoid arthritis (JRA).
  • To review current therapeutic strategies for pediatric arthritis, including immunogenetics and pharmacotherapy.

Main Methods:

  • Analysis of immunogenetic markers (HLA typing) in children with chronic arthritis.
  • Review of clinical studies on methotrexate efficacy in JRA, comparing different doses and placebo.
  • Examination of treatment outcomes for sulfasalazine and corticosteroid therapies (intra-articular, deflazacort, intravenous methylprednisone).

Main Results:

  • Specific HLA associations (DRw13-DRw18, DQw6-DQw18, DPw2) identified for persistent pauciarticular JRA.
  • Moderate-dose methotrexate demonstrated superiority over lower doses and placebo in controlling polyarthritis in JRA.
  • Methotrexate may be particularly beneficial for polyarthritis following a pauciarticular onset.
  • Intra-articular corticosteroids are highlighted for pauciarticular disease; deflazacort shows potential calcium-sparing effects; IV methylprednisone considered for severe cases.

Conclusions:

  • Immunogenetics play a crucial role in understanding the heterogeneity of chronic childhood arthritis.
  • Methotrexate is an effective treatment for polyarticular JRA, especially for those with prior pauciarticular involvement.
  • Further standardization of diagnostic criteria for juvenile spondyloarthropathy and psoriatic arthritis is needed, with HLA-B27 being a potential marker for a subset.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...